S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ZVRA Zevra Therapeutics Inc

8.53

0.29 (3.52%)

After Hours

Last Updated: 15:05:01

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Zevra Therapeutics (NASDAQ:ZVRA)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Zevra Therapeutics Charts.

Zevra Therapeutics (NASDAQ:ZVRA)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Zevra Therapeutics Charts.

Zevra Therapeutics Inc News

Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024
Tuesday 17 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 6 December 2024 (1 month ago) • Edgar (US Regulatory)

Zevra Therapeutics Announces Organizational Changes
Friday 6 December 2024 (1 month ago) • GlobeNewswire Inc.

Zevra Therapeutics to Participate at Upcoming Investor Conferences
Tuesday 26 November 2024 (1 month ago) • GlobeNewswire Inc.

Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C
Thursday 21 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates
Tuesday 12 November 2024 (2 months ago) • GlobeNewswire Inc.

Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting
Monday 11 November 2024 (2 months ago) • GlobeNewswire Inc.

Zevra Therapeutics to Participate at the Guggenheim Securities Healthcare Innovation Conference on Wed, Nov. 13
Wednesday 6 November 2024 (2 months ago) • GlobeNewswire Inc.

More Zevra Therapeutics Inc News Articles

Asia Broadband (PK)

Health Advance (PK)

KULR Technology

GBT Technologies (PK)

TPT Global Tech (CE)

Accredited Solutions (PK)

Decentral Life (PK)

North Bay Resources (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions